Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension. 1991

A Doria, and P Fioretto, and A Avogaro, and A Carraro, and A Morocutti, and R Trevisan, and F Frigato, and G Crepaldi, and G Viberti, and R Nosadini
Istituto di Medicina Interna, Università di Padova, Italy.

The nature of the association between essential hypertension and insulin resistance remains unknown. We measured plasma glucose and insulin levels after an oral glucose tolerance test (OGTT), as well as insulin sensitivity (using a euglycemic hyperinsulinemic clamp), glucose turnover (Rd; using [6,6-2H2]- and [3-3H]glucose isotopic dilution), and forearm net balance of glucose (using arterial-venous difference) in 22 hypertensive patients with high (H2) red blood cell (RBC) sodium-lithium countertransport (Na(+)-Li+ CT; greater than 0.41 mmol.l RBC-1.h-1), 21 hypertensive patients with normal (H1) Na(+)-Li+ CT, and 22 normotensive controls (C). After OGTT, H2 patients had higher plasma glucose and insulin levels than H1 and C. During euglycemic hyperinsulinemia (approximately 100 microU/ml) Rd was lower in H2 [21.7 +/- 1.4 (SE) mumol.kg-1.min-1] than in H1 (44.3 +/- 2.9; P less than 0.01) and C (48.1 +/- 3.0; P less than 0.01), and an inverse correlation was found between rates of Na(+)-Li+ CT and Rd in H1 and H2 (rs = -0.76; P less than 0.01). Forearm glucose uptake was 40-50% lower in H2 compared with H1 and C (P less than 0.01). Lactate concentration increased more in C (from 511 +/- 24 to 1,207 +/- 69 microM) and in H1 (from 564 +/- 40 to 1,122 +/- 99) than in H2 (from 581 +/- 42 to 950 +/- 102, P less than 0.05 vs. both). Forearm blood flow increased more in C (31%, P less than 0.05) and H1 (22%, P less than 0.05) than in H2 (12%).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Doria, and P Fioretto, and A Avogaro, and A Carraro, and A Morocutti, and R Trevisan, and F Frigato, and G Crepaldi, and G Viberti, and R Nosadini
July 1982, The New England journal of medicine,
A Doria, and P Fioretto, and A Avogaro, and A Carraro, and A Morocutti, and R Trevisan, and F Frigato, and G Crepaldi, and G Viberti, and R Nosadini
August 1991, Hypertension (Dallas, Tex. : 1979),
A Doria, and P Fioretto, and A Avogaro, and A Carraro, and A Morocutti, and R Trevisan, and F Frigato, and G Crepaldi, and G Viberti, and R Nosadini
January 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation,
A Doria, and P Fioretto, and A Avogaro, and A Carraro, and A Morocutti, and R Trevisan, and F Frigato, and G Crepaldi, and G Viberti, and R Nosadini
November 1996, Clinica chimica acta; international journal of clinical chemistry,
A Doria, and P Fioretto, and A Avogaro, and A Carraro, and A Morocutti, and R Trevisan, and F Frigato, and G Crepaldi, and G Viberti, and R Nosadini
April 1980, The New England journal of medicine,
A Doria, and P Fioretto, and A Avogaro, and A Carraro, and A Morocutti, and R Trevisan, and F Frigato, and G Crepaldi, and G Viberti, and R Nosadini
January 1982, Hypertension (Dallas, Tex. : 1979),
A Doria, and P Fioretto, and A Avogaro, and A Carraro, and A Morocutti, and R Trevisan, and F Frigato, and G Crepaldi, and G Viberti, and R Nosadini
June 1989, Hypertension (Dallas, Tex. : 1979),
A Doria, and P Fioretto, and A Avogaro, and A Carraro, and A Morocutti, and R Trevisan, and F Frigato, and G Crepaldi, and G Viberti, and R Nosadini
March 1994, Methods and findings in experimental and clinical pharmacology,
A Doria, and P Fioretto, and A Avogaro, and A Carraro, and A Morocutti, and R Trevisan, and F Frigato, and G Crepaldi, and G Viberti, and R Nosadini
March 1996, Journal of internal medicine,
A Doria, and P Fioretto, and A Avogaro, and A Carraro, and A Morocutti, and R Trevisan, and F Frigato, and G Crepaldi, and G Viberti, and R Nosadini
September 1994, Current opinion in nephrology and hypertension,
Copied contents to your clipboard!